Compare SBUX & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBUX | MCK |
|---|---|---|
| Founded | 1971 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.7B | 101.9B |
| IPO Year | 1992 | N/A |
| Metric | SBUX | MCK |
|---|---|---|
| Price | $91.56 | $839.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 13 |
| Target Price | $100.91 | ★ $882.69 |
| AVG Volume (30 Days) | ★ 11.8M | 585.4K |
| Earning Date | 01-28-2026 | 02-04-2026 |
| Dividend Yield | ★ 2.70% | 0.39% |
| EPS Growth | N/A | ★ 66.19 |
| EPS | 1.20 | ★ 32.12 |
| Revenue | $37,701,700,000.00 | ★ $387,094,000,000.00 |
| Revenue This Year | $4.76 | $14.84 |
| Revenue Next Year | $6.95 | $8.34 |
| P/E Ratio | $76.60 | ★ $25.88 |
| Revenue Growth | 4.30 | ★ 17.23 |
| 52 Week Low | $75.50 | $570.51 |
| 52 Week High | $117.46 | $895.58 |
| Indicator | SBUX | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 57.43 |
| Support Level | $90.78 | $818.70 |
| Resistance Level | $104.82 | $849.05 |
| Average True Range (ATR) | 2.78 | 17.25 |
| MACD | -0.38 | 0.93 |
| Stochastic Oscillator | 11.98 | 77.74 |
Starbucks stands out as the world's biggest and most recognizable coffee brand, powered by ultracustomizable beverages in-store and a sweeping footprint of nearly 41,000 cafes in over 80 countries. About 52% are company-operated, with the balance run by licensees. The company operates roasteries and sells across its North America (74% of revenue as of the end of fiscal 2025), international (21%), and channel development (5%) segments. The brand collects revenue from company-operated stores, licensee royalties, equipment and product sales, retail ready-to-drink beverages, and packaged coffee.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.